Clinical Trial Update: Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC

View source ↗

Summary

This clinical trial update reports on the efficacy of EGFR tyrosine kinase inhibitors in patients with rare EGFR-mutated non-small cell lung cancer. The current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• EGFR tyrosine kinase inhibitors (class)

Snippet

Sponsor: Ulsan University Hospital | Conditions: Lung Neoplasms | Status: UNKNOWN